SEGALL BRYANT & HAMILL, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2023$5,507,342
+63827.4%
291,857
-87.0%
0.06%
-37.6%
Q1 2023$8,615
-23.6%
2,243,746
-1.4%
0.09%
-26.2%
Q4 2022$11,281
-99.7%
2,274,564
+158.8%
0.13%
+152.0%
Q3 2022$4,199,000
+9.1%
878,961
+2.8%
0.05%
+16.3%
Q2 2022$3,847,000
-4.3%
854,646
+1.2%
0.04%
+13.2%
Q1 2022$4,020,000844,1630.04%
Other shareholders
IMMUNOGEN INC shareholders Q3 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders